Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -72.84% is 86% above its 5-year average of -509.31%, near the high end of its 5-year range (-2059.11%–52.18%).
90.55% above its 12-month average of -770.54%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1380.73%.
OPERATING MARGIN
-72.84%
OPERATING MARGIN AVG TTM
-770.54%
OPERATING MARGIN AVG 3Y
-640.03%
OPERATING MARGIN AVG 5Y
-509.31%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+90.55%
CURRENT VS 3Y AVG
+88.62%
CURRENT VS 5Y AVG
+85.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 643 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
IDEAYA Biosciences, Inc.
Market Cap
$3.54B
Operating Margin
-72.84%
TTM Avg
-770.54%
3Y Avg
-640.03%
5Y Avg
-509.31%
Market Cap
$3.50B
Operating Margin
-1.17%
TTM Avg
-12.22%
3Y Avg
-19.38%
5Y Avg
-20.83%
Market Cap
$3.43B
Operating Margin
7.59%
TTM Avg
16.94%
3Y Avg
-4.86%
5Y Avg
-19.92%
Market Cap
$3.32B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.09B
Operating Margin
-3.25%
TTM Avg
-34.29%
3Y Avg
-2164.03%
5Y Avg
-1442.69%
Market Cap
$3.08B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-93.42%
5Y Avg
-160.46%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | $3.54B | -72.84% | -770.54% | -640.03% | -509.31% |
| Celcuity Inc. (CELC)vs › | $3.54B | 0.00% | 0.00% | 0.00% | 0.00% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.50B | -1.17% | -12.22% | -19.38% | -20.83% |
| CareDx, Inc (CDNA)vs › | $3.44B | -0.92% | 2.81% | -22.73% | -18.78% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.43B | 7.59% | 16.94% | -4.86% | -19.92% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.32B | 0.00% | 0.00% | 0.00% | 0.00% |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 5.04% | 3.30% | 1.43% | 3.80% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | -3.25% | -34.29% | -2164.03% | -1442.69% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.08B | 0.00% | 0.00% | -93.42% | -160.46% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.08B | 0.00% | -180.11% | -313.94% | -1209.42% |
Gross Margin
-43.9%
Operating Margin
-72.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1380.73% |
| 2026-03-31 | -1654.63% |
| 2025-12-31 | -869.53% |
| 2025-09-30 | 52.18% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -2059.11% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -1068.49% |
| 2023-09-30 | -417.09% |
| 2023-06-30 | -922.94% |
| 2023-03-31 | -333.49% |
| 2022-12-31 | -657.48% |
| 2022-09-30 | 2.22% |
| 2022-06-30 | -384.53% |
| 2022-03-31 | -125.19% |
| 2021-12-31 | -619.95% |
| 2021-09-30 | -130.49% |
| 2021-06-30 | -126.21% |
| 2021-03-31 | -126.05% |
| 2020-12-31 | -49.95% |
| 2020-09-30 | -55.72% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
